Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05791071 · ClinicalTrials.gov registry record · Phase 2
Virtual Reality Intervention for Skill Acquisition Support in Autism Spectrum Disorder (ASD)
A Phase 2 study, sponsored by Floreo.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT05791071 is a Phase 2 study that has completed, run by Floreo. The registered enrollment target is 30 participants.
The verdict
NCT05791071, a Phase 2 study, has completed, sponsored by Floreo.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
A Randomized Controlled Phase II study to assess the efficacy of Floreo VR (Virtual reality) Building Social Connections as treatment for social skills in children with Autism Spectrum Disorder (ASD)
Interventions
- DEVICE Sham
- DEVICE Floreo VR Building Social Connections
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-02-15 |
| Est. Completion | 2023-06-29 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05791071
The ClinicalTrials.gov registry entry for NCT05791071 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Floreo, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sham is the first listed.
NCT05791071 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05791071 about?
NCT05791071 is a clinical study titled "Virtual Reality Intervention for Skill Acquisition Support in Autism Spectrum Disorder (ASD)". A Randomized Controlled Phase II study to assess the efficacy of Floreo VR (Virtual reality) Building Social Connections as treatment for social skills in children with Autism Spectrum Disorder (ASD)
What is the current status of trial NCT05791071?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2023-02-15. Estimated completion is 2023-06-29.
What interventions are being tested in trial NCT05791071?
The interventions under investigation include: Sham (DEVICE), Floreo VR Building Social Connections (DEVICE).
Who is sponsoring clinical trial NCT05791071?
This trial is sponsored by Floreo, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.